Sevo Nutraceuticals Features PERCEPTIV™ at Pharmacy Business Growth Conference

Share Article

Clinically Proven for Cognitive Health, PERCEPTIV to be Featured in Booth #36 at PDS Conference in Orlando

News Image
The deep science behind PERCEPTIV resonates with pharmacists that are seeking high quality, proven nutraceuticals to offer their customers.

Sevo Nutraceuticals, Inc. reinforces its commitment to independent pharmacies nationwide by showcasing its cornerstone product, PERCEPTIV™, at Pharmacy Development Services’ national conference at the Gaylord Palms Orlando, February 21-23, 2013. Sevo Nutraceuticals launched PERCEPTIV in August 2012 and has been selling to consumers through select independent pharmacies and health food stores throughout the United States At the PDS conference, Sevo will continue expanding its network of independent pharmacies to reach the growing demand for clinically proven cognitive health products.

Cognitive health is a critical health issue in the United States. It impacts the largest demographic in America—the Baby Boomers--who number 74 million, according to US Census data. Many boomers are deeply concerned about declining cognitive function. Based on a report by the National Council on Aging, Americans are twice as fearful of losing mental capacity as having diminished physical ability and 60% of adults are very or somewhat worried about memory loss. This data points to a growing need for cognitive health products that are effective, safe, and available over the counter to meet the demand for cognitive solutions today.

PERCEPTIV,, can be part of the solution. PERCEPTIV is a unique patents pending blend of six vitamins and clinically researched nutrients needed to maintain cellular health and vitality in the brain. The formula is the result of over 20 years of research and five published, independent clinical studies directed by the University of Massachusetts Lowell.

The unique formulation found in PERCEPTIV, Vitamin E, Folic Acid, Vitamin B12 and a Proprietary blend of N-Acetyl Cysteine, Acetyl L-Carnitine and S-Adenosyl Methionine (SAMe), has been shown to:

-Protect against normal cognitive decline associated with aging
-Improve list recall by more than 100%
-Improve executive function by an average of 20%
-Increase focus and concentration
-Support a healthy mood
-Provide effective cognitive enhancement in adults of all ages*

“We have found that the deep science behind PERCEPTIV resonates with pharmacists that are seeking high quality, proven nutraceuticals to offer their customers. The PDS conference is an excellent opportunity to reach pharmacy owners and discuss the PERCEPTIV opportunity with them. We are excited to expand our partnerships with committed independent pharmacies. Pharmacists around the US are confidently recommending PERCEPTIV to their customers knowing that it is proven effective and safe in clinical studies involving hundreds of participants,” said Steve Swenson, CMO of Sevo Nutraceuticals, Inc.

Please visit Sevo Nutraceuticals at Booth #36 to take advantage of reseller show specials or contact Steve Swenson, Chief Marketing Officer, at 860-748-9608 or steves(at) to set up an appointment at the PDS Conference.

About PDS
Pharmacy Development Services (PDS) has given the independent pharmacy owner new tools, innovative technologies, resources and strategies, such as a “Shop Local” campaign, to allow them to truly own their pharmacy, instead of it owning them. To learn more go to

About Sevo Nutraceuticals, Inc.

Sevo Nutraceuticals was established in 2012 to license and market science-based nutraceuticals. Its vision is to become a market leader in highly efficacious, scientifically researched nutraceuticals that improve people's lives. The Company's mission is to build a select portfolio of high value products with clear markets which are leaders in their category.

Sevo’s cornerstone product, PERCEPTIV™ was licensed from UMass Lowell in 2012 and was developed under the leadership of UMass Lowell Professor Thomas B. Shea, Director of the Center for Cellular Neurobiology and Neurodegeneration Research.

  • These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bernie Prusaczyk, CEO
Visit website